American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update.
Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D.
J Oral Maxillofac Surg. 2022 May;80(5):920-943. doi: 10.1016/j.joms.2022.02.008. Epub 2022 Feb 21.
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.
Anastasilakis AD, Pepe J, Napoli N, Palermo A, Magopoulos C, Khan AA, Zillikens MC, Body JJ.
J Clin Endocrinol Metab. 2022 Apr 19;107(5):1441-1460. doi: 10.1210/clinem/dgab888.
Pentoxifylline and tocopherol protocol to treat medication-related osteonecrosis of the jaw: A systematic literature review.
Cavalcante RC, Tomasetti G.
J Craniomaxillofac Surg. 2020 Nov;48(11):1080-1086. doi: 10.1016/j.jcms.2020.09.008. Epub 2020 Sep 18.
Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.
Nicolatou-Galitis O, Kouri M, Papadopoulou E, Vardas E, Galiti D, Epstein JB, Elad S, Campisi G, Tsoukalas N, Bektas-Kayhan K, Tan W, Body JJ, Migliorati C, Lalla RV; MASCC Bone Study Group.
Support Care Cancer. 2019 Feb;27(2):383-394. doi: 10.1007/s00520-018-4501-x. Epub 2018 Oct 23.
Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients.
Soutome S, Otsuru M, Hayashida S, Murata M, Yanamoto S, Sawada S, Kojima Y, Funahara M, Iwai H, Umeda M, Saito T.
Sci Rep. 2021 Aug 26;11(1):17226. doi: 10.1038/s41598-021-96480-8.
Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial.
Sim IW, Borromeo GL, Tsao C, Hardiman R, Hofman MS, Papatziamos Hjelle C, Siddique M, Cook GJR, Seymour JF, Ebeling PR.
J Clin Oncol. 2020 Sep 10;38(26):2971-2980. doi: 10.1200/JCO.19.02192. Epub 2020 Jul 2.
Medication-Related Osteonecrosis of the Jaw.
Chen YF, Chang HP.
N Engl J Med. 2023 May 25;388(21):e69. doi: 10.1056/NEJMicm2209172. Epub 2023 May 20.
Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management.
Kün-Darbois JD, Fauvel F.
Morphologie. 2021 Jun;105(349):170-187. doi: 10.1016/j.morpho.2020.11.008. Epub 2020 Dec 3.
Systematic review of medication related osteonecrosis of the jaw (MRONJ) in patients undergoing only antiangiogenic drug therapy: surgery or conservative therapy?
Sacco R, Woolley J, Patel G, Calasans-Maia MD, Yates J.
Br J Oral Maxillofac Surg. 2022 Feb;60(2):e216-e230. doi: 10.1016/j.bjoms.2021.03.006. Epub 2021 Mar 24.
The Role of the Immune Response in the Development of Medication-Related Osteonecrosis of the Jaw.
Zhang W, Gao L, Ren W, Li S, Zheng J, Li S, Jiang C, Yang S, Zhi K.
Front Immunol. 2021 Feb 25;12:606043. doi: 10.3389/fimmu.2021.606043. eCollection 2021.
